Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (1562)	11/9/1999 6:01:00 PM
From: Eric Fader	Read Replies (1) \| Respond to of 5582

Bryant Cragun? <g>

To: Sir Auric Goldfinger who wrote (1562)	11/9/1999 6:13:00 PM
From: DanZ	Respond to of 5582

You're right Auric. Nobody is expecting a profit for Q3 99. I estimate that they will lose 4 cents in the third quarter. The thing that one should be concerned about if they are short is if the company releases forward looking statements about the fourth quarter, and in particular sales of Zicam. If you look at the last few quarterly releases, Gum Tech typically reveals data about the current quarter to give investors guidance about the future. This is after all, more important than past earnings when making investment decisions. It is my belief that sales of Zicam are going very well and that the company will show a profit in Q4. If the company releases positive forward looking statements, the stock will most likely trade higher. BTW, the article wasn't "rejected" as you have falsely characterized it. It was withdrawn as I'm sure you are aware. The only thing that deception will get you is a lack of respect. It won't move the stock in the direction that you want it to go. Luck, Dan